» Articles » PMID: 11230742

Bile Acid-induced Rat Hepatocyte Apoptosis is Inhibited by Antioxidants and Blockers of the Mitochondrial Permeability Transition

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2001 Mar 7
PMID 11230742
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

The accumulation of hydrophobic bile acids plays a role in the induction of apoptosis and necrosis of hepatocytes during cholestasis. The aim of this study was to determine in freshly isolated rat hepatocytes the roles of oxidant stress and the mitochondrial permeability transition (MPT) in bile acid-induced apoptosis. Hepatocytes isolated from adult male Sprague-Dawley rats were incubated for 4 hours in buffer containing the hydrophobic bile acid, glycochenodeoxycholic acid (GCDC, 0-500 micromol/L) or the hydrophilic bile acid, glycocholic acid (GCA), and either the antioxidants, alpha tocopherol, ebselen, or idebenone (a coenzyme Q analogue); or the MPT blockers, cyclosporin A, or bongkrekic acid, or a caspase-8 inhibitor. Apoptosis was assessed hourly by nuclear morphologic changes of fixed cells by DAPI fluorescence microscopy and reactive oxygen species (ROS) generation by dichlorofluorescein fluorescence of hepatocytes. The percent of cells undergoing apoptosis increased in a time- and concentration-dependent manner in cells exposed to GCDC, and to a much lesser extent to GCA. ROS generation preceded the onset of apoptosis. MPT blockers, caspase-8 inhibition, and antioxidants prevented apoptosis and reduced ROS generation by hepatocytes. Flow cytometry analysis showed that MPT occurred within 1 hour of exposure of cells to 100 micromol/L GCDC, prior to onset of significant apoptosis. In conclusion, ROS generation, MPT induction, and cytochrome c release are critical steps in the induction of apoptosis by bile acids. Antioxidants may reduce liver injury caused by low levels of bile acids by preventing the generation of oxidant stress and subsequent stimulation of the MPT and release of cytochrome c from mitochondria.

Citing Articles

Association of Fontan Pathophysiology With Plasma Bile Acids.

Shah A, Surendran A, Hassan-Tash P, Turnbull C, Johnston N, Goodlett D JACC Adv. 2025; 4(2):101563.

PMID: 39827765 PMC: 11787425. DOI: 10.1016/j.jacadv.2024.101563.


Clinical Significance of Serum Bile Acid Profiles in Fatty Liver.

Sun H, Wu L, Xu M, Zheng E, Yu Y, Ye Y Diabetes Metab Syndr Obes. 2024; 17:4843-4856.

PMID: 39722833 PMC: 11668968. DOI: 10.2147/DMSO.S494810.


Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects.

Zhang X, Shi L, Lu X, Zheng W, Shi J, Yu S Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338306 PMC: 11435149. DOI: 10.3390/ph17091142.


The Role of Epicardial Adipose Tissue-Derived Proteins in Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation: A Bioinformatics Analysis.

Huang K, Lu J, Li Q, Wang C, Ding S, Xu X J Inflamm Res. 2024; 17:6093-6111.

PMID: 39257896 PMC: 11385935. DOI: 10.2147/JIR.S466203.


Hepatic macrophage niche: a bridge between HBV-mediated metabolic changes with intrahepatic inflammation.

Wang J, Lu H, Li Q Front Immunol. 2024; 15:1414594.

PMID: 39091506 PMC: 11291371. DOI: 10.3389/fimmu.2024.1414594.